Additional regulatory review pathways can facilitate faster dossier approvals in South Africa
Magister Pharmaceuticae - MPharm === The objective of the study was to perform a comparative review of pathways, timelines and improvements of countries with markets that the South African Health Products Authority (SAHPRA) benchmark themselves against. Furthermore, this study intends to identify th...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
University of the Western Cape
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11394/7878 |